|
|
|
|
|
|
|
|
|
|
Previous: INTERFERON SCIENCES INC, 10-Q, 2000-11-14 |
Next: RUSSELL FRANK INVESTMENT CO, 497, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000351532
<NAME> INTERFERON SCIENCES, INC.
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 4,787,144
<SECURITIES> 0
<RECEIVABLES> 217,505
<ALLOWANCES> 0
<INVENTORY> 585,389
<CURRENT-ASSETS> 5,599,441
<PP&E> 12,759,273
<DEPRECIATION> 10,190,236
<TOTAL-ASSETS> 8,545,848
<CURRENT-LIABILITIES> 3,448,988
<BONDS> 0
0
0
<COMMON> 170,452
<OTHER-SE> 4,926,408
<TOTAL-LIABILITY-AND-EQUITY> 8,545,848
<SALES> 645,471
<TOTAL-REVENUES> 645,471
<CGS> 1,210,880
<TOTAL-COSTS> 1,210,880
<OTHER-EXPENSES> 2,373,285
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (2,905,398)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,905,398)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,905,398)
<EPS-BASIC> (.28)
<EPS-DILUTED> (.28)
</TABLE>
|
|